Low impact of staging EUS for determining surgical resectability in esophageal cancer

Assessment of EUS for diagnosing, staging, and determining resectability of pancreatic cancer: a review.

Pancreatic cancer has a dismal prognosis, but surgery offers a potential for cure in a minority of patients with localized disease. An in-depth review by Gudjonsson1 of 4100 patients with pancreatic tumor resection found a 5-year survival rate of 3.5%. More recent studies have found improved 5and 7year survival rates of 19% and 11%, respectively, in highly selected surgical patients.2 This may ...

Staging of Esophageal Cancer: Is Eus Necessary?

Thoracoscopic staging and surgical therapy for esophageal cancer.

Esophageal cancer continues to be a major health problem with an associated poor prognosis. New technology is being applied to the staging of this cancer. The new staging system requires assessment of depth of wall penetration and lymph node status prior to resection. To determine penetration and node status with a high degree of accuracy generally requires some combination of chemotherapy, mag...

Gastric Cancer Staging: EUS And CT

INTRODUCTION Gastric cancer is the fourth most common cancer and the second leading cause of death from cancer. Only complete resection of all gross disease with negative microscopic margins (R0 resection) provides a long-term survival benefit, and the overall 5-year relative survival rate is approximately 20%. To improve survival and quality of life, new therapeutic approaches have been introd...

Utility of tumor markers in determining resectability of pancreatic cancer.

HYPOTHESIS Despite advances in preoperative radiologic imaging, a significant fraction of potentially resectable pancreatic cancers are found to be unresectable at laparotomy. We tested the hypothesis that preoperative serum levels of CA19-9 (cancer antigen) and carcinoembryonic antigen will identify patients with unresectable pancreatic cancer despite radiologic staging demonstrating resectabl...